Abstract
Objectives This study aimed to investigate the risk miRNAs (microRNAs) for AML (acute myeloid leukemia) prognosis and related regulatory mechanisms. Methods MiRNA and gene expression data, as well as clinical data of 176 patients were first downloaded from TCGA. Then miRNAs and genes significantly affecting the survival time based on KM survival curve were identified using Log Rank test. Next, COX proportional-hazard regression analysis was performed to screen the risk miRNAs (P-value < 0.05). Common genes from survival analysis and predicted by miRWalk were used to construct the miRNA regulatory network with the risk miRNAs. Finally, a protein-protein interaction (PPI) network was constructed, as well as functional annotation and pathway enrichment analysis. Results The survival analysis revealed 33 miRNAs and 1,377 genes significantly affecting the survival time. HR values of nine miRNAs (up-regulated hsa-mir-606, 520a, 137, 362, 599, 600, 202, 639and down-regulated 502) were either >1 or <1. The miRNA regulatory network contained 477 nodes and 944 edges. The top ten genes of the constructed PPI network were EGFR, EIF4G1, REL, TOP1, COL14A1, HDAC3, MRPL49, PSMA2, TOP2A and VCAM1 successively. According to pathway enrichment a...Continue Reading
References
Nov 4, 2000·Nature Genetics·S C TsaiE Seto
Apr 21, 2001·Blood·M ToyotaJ P Issa
Mar 21, 2002·Nature Reviews. Cancer·P MarksW K Kelly
Nov 5, 2003·Genome Research·Paul ShannonTrey Ideker
Feb 3, 2004·Oncogene·Thomas D GilmoreDaniel T Starczynowski
Mar 24, 2004·Cancer Genetics and Cytogenetics·Leonardo PotenzaGiuseppe Torelli
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan FröhlingRoss L Levine
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Dec 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Shuangli MiJianjun Chen
Jan 12, 2008·Blood·Ramiro GarzonCarlo M Croce
Mar 14, 2008·Blood·Mojca Jongen-LavrencicBob Löwenberg
May 3, 2008·The New England Journal of Medicine·Guido MarcucciClara D Bloomfield
May 15, 2008·PloS One·Amanda Dixon-McIverSilvana Debernardi
Jun 5, 2008·Blood·Heike KroegerJean-Pierre J Issa
Feb 6, 2009·Leukemia·C FlothoM Lübbert
Jul 30, 2009·Blood·Warren FiskusKapil N Bhalla
Sep 3, 2009·Molecular Cancer·Edurne San José-EnérizXabier Agirre
Sep 9, 2009·The Journal of Biological Chemistry·Taeko WadaYusuke Furukawa
Oct 13, 2009·Molecular Cell·Aster H JuanVittorio Sartorelli
Nov 12, 2009·Blood·Lars BullingerDirk van den Boom
Jan 12, 2010·Cancer Cell·Maria E FigueroaAri Melnick
Aug 13, 2010·Nature·Huili GuoDavid P Bartel
Sep 22, 2010·Nucleic Acids Research·Amanda C GentryNeil Osheroff
Sep 30, 2010·Blood·Giridharan RamsinghDaniel C Link
Jan 19, 2011·Haematologica·Diana SchotteMonique L Den Boer
May 25, 2011·Journal of Biomedical Informatics·Harsh DweepNorbert Gretz
Sep 8, 2011·Cell Cycle·Simone BoehrerGuido Kroemer
Nov 11, 2011·Wiley Interdisciplinary Reviews. RNA·Shobha Vasudevan
Jul 25, 2012·BMC Cancer·Anne MuratiDaniel Birnbaum
Nov 23, 2012·Cell Cycle·Federica SotgiaMichael P Lisanti
Dec 4, 2012·Nucleic Acids Research·Andrea FranceschiniLars J Jensen
Dec 19, 2013·PloS One·Ilaria LeporeLucia Altucci
Dec 30, 2014·Oncotarget·Aaron RaymondLalitha Nagarajan